Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against QuidelOrtho Corporation. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is QuidelOrtho Corporation (QDEL) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of QuidelOrtho Corporation (NASDAQ: QDEL).
On November 3, 2026, QuidelOrtho announced its third-quarter financial results, reporting revenue of $618.9 million, a decrease of 11.6% from the prior-year quarter. The Company also narrowed its full-year revenue outlook and announced a restructuring program. Management reported a 45% decline in China revenue on a constant-currency basis, a 27% decline in point-of-care revenue, and a 39% decline in respiratory revenue. Following this news, QuidelOrtho shares fell 10.6% to $12.63 in after-hours trading on that same day.
What Potential Securities Violations Is BG&G Investigating?
- Whether QuidelOrtho Corporation and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether QuidelOrtho Corporation failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should QuidelOrtho Corporation (QDEL) Investors Do?
If you purchased or acquired QDEL securities and suffered a loss, you may have a claim.
Contact BG&G to share relevant facts or information about your purchase.
There is no cost or obligation — our firm works exclusively on a contingency fee basis.
You do not need to have sold your shares to contact us.
How Is QuidelOrtho Corporation (NASDAQ: QDEL) Stock Trading Today?
Interactive chart showing the weekly share price history of NASDAQ:QDEL (NASDAQ:QDEL).
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”